Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results.

Overview of attention for article published in Journal of Rheumatology, April 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news: 2 news outlets

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 14 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Artrite reumatoide, farmaci biologici meglio accompagnati da DMARD

Pharmastar Italy, 04 Jun 2019

L'utilizzo dei DMARDcs in pazienti affetti da artrite reumatoide (AR), in concomitanza con i DMARDb, si associa ad una…

Concomitant csDMARD Use Linked to Reduced Risk for bDMARD Discontinuation in RA

Medical Health News, 30 Apr 2019

The concurrent use of conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) and biologic DMARDs (bDMARDs) was…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.